ArticleBMC pediatrics2010

Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5).

Robbin Itzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.